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Abstract Consumers often have a positive attitude to the
option of receiving personalized nutrition advice based
upon genetic testing, since the prospect of enhancing or
maintaining one’s health can be perceived as empowering.
Current direct-to-consumer services over the Internet,
however, suffer from a questionable level of truthfulness
and consumer protection, in addition to an imbalance
between far-reaching promises and contrasting disclaimers.
Psychological and behavioral studies indicate that con-
sumer acceptance of a new technology is primarily
explained by the end user’s rational and emotional inter-
pretation as well as moral beliefs. Results from such studies
indicate that personalized nutrition must create true value
for the consumer. Also, the freedom to choose is crucial for
consumer acceptance. From an ethical point of view,
consumer protection is crucial, and caution must be exer-
cised when putting nutrigenomic-based tests and advice
services on the market. Current Internet offerings appear to
reveal a need to further guaranty legal certainty by ensuring
privacy, consumer protection and safety. Personalized
nutrition services are on the borderline between nutrition
and medicine. Current regulation of this area is incomplete
and undergoing development. This situation entails the
necessity for carefully assessing and developing existing
rules that safeguard fundamental rights and data protection
while taking into account the sensitivity of data, the risks
posed by each step in their processing, and sufficient
guarantees for consumers against potential misuse.
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Introduction
The prospect of using nutrigenomics science for person-
alized nutritional advice based upon individual genetic
information appears to be commercially attractive—as
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indicated by the emergence of companies offering such
services. Personalized nutrition fits into an ongoing mar-
keting trend in which consumer–supplier relationships
increasingly move from a commodity model toward a
personalized model. Public attitudes to new technologies
are among the most important factors that determine the
successful implementation of any technology (Sjöberg
2005), and personalized nutrition is no exception.
Nutrigenomics is a relatively young scientific field, and
it is surrounded by considerable uncertainty regarding its
actual deliverables for health improvement (see Görman
et al. 2012 this issue). Because of this, efforts in using
nutrigenomics to offer individual tailor-made nutritional
advice raise a number of questions. In this paper, we
review some of the most crucial ethical and legal concerns
related to the commercialization of personalized nutrition
advice based on genetic information. We identify such
concerns primarily with respect to consumers using the
Internet.
Consumer attitudes
Several studies indicate that the European public often
holds a positive attitude toward genetic testing and per-
sonalized nutrition. In a pan-European study into consumer
attitudes toward genetic testing and personalized nutrition,
66 % of the respondents stated that they would be willing
to undergo a genetic test and 27 % would be willing to
follow a personalized diet. Those who were willing to
undergo a genetic test for personalized advice more often
had high blood cholesterol, obesity, and high stress levels
than those willing to take a genetic test out of general
interest. Respondents who were unwilling to take a genetic
test were more often male and less often obese. Those who
were aware of health problems related to the metabolic
syndrome were particularly in favor of receiving person-
alized dietary advice (Stewart-Knox et al. 2009).
A questionnaire study conducted in Sweden also
revealed interest in the use of personalized nutrition ser-
vices. Here, 70 % of respondents declared that they would
be willing to undergo a genetic test in order to receive such
nutritional advice. Among the respondents, 65 % stated
that they would be willing to have their under-age children
tested (Ahlgren, in prep). More often than older respon-
dents (aged 46–79 years), younger ones (aged 16–45 years)
indicated that they were interested in personalized nutri-
tional advice based on genetic tests. In contrast to the
results of the above study by Stewart-Knox et al., this
willingness did not correlate with any kind of self-reported
health problems (77 % of subjects described their health as
good or very good). Clearly, if personalized dietary advice
is to have any positive effect for the consumer, they will
actually have to follow the advice given. In the Ahlgren
study, 65 % of the respondents asserted that they would
follow such personalized advice, whereas 20 % said that
their willingness was dependent on the likelihood or
unlikelihood of developing any serious disease if the
advice was not followed (Ahlgren, in prep.). This could be
taken to mean that known disease risks may motivate
respondents to follow dietary advice.
An interview study, using informants sampled from the
above Swedish questionnaire study, confirmed the initial
quantitative results. In the interview study, informants were
asked about the reasons and motives underlying their
willingness (or unwillingness) to make use of nutrigenomic
services. As anticipated, the informants made it clear that
good health was of great value to them and what they
expected from personalized dietary advice was personal
empowerment in relation to their health. Informants also
stressed the fact that relatives, for example, children and
siblings, could benefit from the results and the advice given
(Ahlgren, in prep.). In addition to the results from Stewart-
Knox et al., these findings indicate that a feeling of per-
sonal relevance contributes to a positive attitude toward
nutrigenomics-based personalized nutrition.
Although respondents and informants in the Swedish
studies displayed a positive attitude toward gene-based
personalized dietary advice, they also expressed some
concerns regarding ethical matters. In the questionnaire
study, 63 % of respondents were concerned that genetic
information might end up in the wrong hands, for example,
with insurance companies or employers (Ahlgren, in prep.;
Chadwick 2004). Such concerns call for a well-defined
legal framework regarding not only the collection of
genetic data, but also the storage of both DNA and infor-
mation based on such data. Another identified area of
ethical apprehension was related to legal aspects. Who may
benefit from these nutrigenomic services? At present, such
services are not available for everyone, partly owing to
economic factors (Ahlgren, in prep.). Wendel et al. (2009)
identify an additional ethical concern raised by consumers.
Results from their study indicate that consumers are wary
of commercial interests, as exemplified by the following
areas of disapproval: branded personalized nutrition;
commercial ownership of database technology that trans-
lates a consumer’s profile into personalized nutritional
advice; and commercial fitness clubs offering personalized
nutrition.
Thus, good health is of great importance to consumers,
and the opportunity for self-managed health appears to
have appeal and is perceived as empowering despite some
concerns regarding ethical and legal matters and fears.
Even at the early stage of investigating the connection
between genotypes and responses to dietary factors, it was
foreseen that such knowledge might be used to provide
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individual, tailor-made nutritional advice. It was under-
stood that this might raise consumer interest and create
business opportunities.
Personalized nutrition services on the internet
Over the last decade, a substantial number of Internet
companies have offered personalized information based
upon individual DNA (Ronteltap et al. 2012). Not all of
these companies offer health-related information. Other
services that may be offered include paternity testing,
genetic ancestry testing, and testing for such matters as
the probability of baldness and sensitivity to bitter
tastes. In addition, among the health-focused companies,
not all are concerned with providing consumers with
advice concerning eating and lifestyle habits. Another
important branch is pharmacogenetics, which is not
addressed in the present paper. However, a few com-
panies—albeit fewer than some years ago—offer nutri-
genomic testing.
The activities of online nutrigenomic companies have
been subjected to strong criticism, not least from the US
Government Accountability Office, which questions the
utility of nutrigenomic tests and personalized advice. It
states that the companies it has investigated mislead
consumers by offering them health-related information
that is meaningless, and predictions that are medically
unproven (US Government Accountability Office 2006,
2010).
In spite of such criticism, many companies still offer
DNA information on a direct-to-consumer (DTC) basis
over the Internet. They often achieve this by using a variety
of rhetorical tools. Several of them promise practical
benefits and use prestigious words indicative of strong
health benefits. In particular, it is common to appeal to
‘‘empowerment’’ and ‘‘identity’’ (Nordgren and Juengst
2009; Nordgren 2012)—concepts that are potentially
appealing to consumers. DNA information is said to
empower the individual, that is, help them take control over
their own health by providing access to genetic information
and stimulating them to take medical or preventive mea-
sures. Some examples illustrate this point:
Navigenics is the leading provider of clinically gui-
ded genetic analysis. Our goal is to empower you
with genetic insights to help motivate you to improve
your health. We also put a premium on privacy,
keeping you in control of your genetic information.
(Navigenics 2011).
Getting to know your personal genome will empower
you and provide you with a road map to improve your
health. (deCODEme 2011).
Some companies also appeal to identity or the cus-
tomer’s self-image. In their appeal to personal identity, the
companies stress that DNA information provides knowl-
edge pertinent to it. Two examples illustrate this:
You are unique. That’s exactly why your personal
genetic test from Inherent Health is such a valuable
step towards a life time of good health. The genetic
tests offer personalized guidance for consumers
looking for evidence-based insights on how their
genes may impact their health and wellness. (Inter-
leukin 2011).
By tapping into advances in DNA analysis and
offering education, tools, and expertise, we at
23andMe want to help others take a bold, informed
step toward self-knowledge. (23andMe 2011).
Given that the resulting information is correct and rel-
evant, nutrigenomic tests may be useful for consumers. In
the debate concerning health-related DNA DTC testing, the
key arguments in favor of nutrigenomic DTC testing are as
follows: (1) Nutrigenomic DTC testing may help individ-
uals find a diet that matches their genes and fulfills their
nutritional needs, thereby improving their health; (2) It
may help people find more efficient ways of reducing their
weight, for example, focusing on carbohydrates rather than
fat or vice versa. The arguments against such testing
include the following: (1) Nutrigenomic tests are scientif-
ically unvalidated, inadequate, and premature; (2) There is
a risk of misinterpreting test results. With some exceptions,
Internet companies offer no genetic counseling, which
augments the risk of misinterpretation; (3) The information
is much less instructive than the companies indicate. Often
the consumer is merely offered common sense advice, such
as that they should quit smoking, exercise, and eat fewer
unhealthy foods. In addition, some companies’ disclaimers
make it clear that there are limitations to what should be
expected. Some examples illustrate this:
The Genetic Scan product is for informational pur-
poses only, is not medical advice, and is not a sub-
stitute for professional medical advice, genetic
counseling, diagnosis, or treatment. You must seek
the advice of your physician or other qualified health
provider with any questions you may have regarding
the genetic aspects of a medical matter and you must
not disregard professional medical advice or delay
seeking it because of the results of your Genetic Scan
or anything you have read on the deCODEme Site.
(deCODEme 2011).
The Services provided by Interleukin are solely for
research and educational purposes and uses. Although
based on scientific research, the Services, including
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all information about genetic findings and probabili-
ties, shall not be relied upon by you or any other
person to diagnose, treat or prevent any disease or
health condition… We do not warrant the accuracy,
effectiveness and suitability of this information.
(Interleukin 2011).
Unless the consumer reads and understands the fine
print, this imbalance between far-reaching promises of
empowerment and the contrasting disclaimers may pose a
problem. It is thus clear that there is a need for legal reg-
ulation of nutrigenomic genetic testing (Nordgren 2012).
Although current knowledge about the interaction
between individual genotype, metabolism, and health is still
fragmentary, nutrigenetic analysis of a gene test can in cer-
tain limited cases make it possible to provide consumers with
information about individual health risks (see Görman et al.
2012 this issue). Such information may motivate the indi-
vidual to change their dietary habits and lifestyle for the
better. However, the possible gain rests on the level of
accuracy and consumer security throughout the process of
personalized nutrition services. This ethically complex sit-
uation calls for action to safeguard the consumer. Though
nutrigenomic products are already on the market, the results
of nutrigenomic research and the possibilities for evidence-
based personalized advice are still at an immature stage. The
need for legal regulation is thus of particular significance.
Consumers and new technologies
In a conceptual framework for consumer acceptance of
technology-based food innovation, characteristics of the
technology, the consumer, and the social system together
influence the consumer’s willingness to accept that tech-
nology. These characteristics trigger one or more psycho-
logical processes, for example, a rational trade-off between
a technology’s benefits and costs, or more emotional per-
ceptions of risk and uncertainty. The means of communi-
cation influence which of the characteristics and which of
the psychological processes have the strongest influence on
consumer acceptance. Hence, acceptance is primarily
explained by the end users’ interpretation of the technol-
ogy, including their moral beliefs about it (Ronteltap et al.
2007; Sjöberg 2005). In the case of nutrigenomics, studies
indicate that it would be beneficial for public acceptance if
expert stakeholders were to communicate unanimously
about the technology, if the actual spin-off products pro-
vided clearly recognizable advantages to the consumer, and
if the technology could be easily implemented in daily life.
Public acceptance is particularly enhanced if the consumer
has the freedom to choose whether or not he wishes to
make his genetic profile available (Ronteltap et al. 2009).
Results from the above consumer studies indicate a few
key issues. Personalized nutrition must create true value for
the consumer one way or another. Consumers will critically
evaluate personalized nutrition on the basis of perceived
benefits to them—either direct benefits that accrue to the
consumer personally or indirect benefits for another group
in society. Also, the freedom to choose whether or not to
use nutrigenomic genetic testing—instead of being forced
into it or tempted by deceitful means—is crucial for con-
sumer acceptance. Taking into account consumers’ hesi-
tance toward commercial interests and questions about
genetic data samples and information, it is clear that some
caution must be exercised when putting nutrigenomic-
based tests and advice services on the market. That is even
more pertinent if we realize that for companies to be
profitable, a certain degree of customer lock-in is requisite.
Finding the optimal solution to this potential disparity is a
task for those studying or promoting the further develop-
ment of nutrigenomics-based personalized nutrition.
Legal aspects of personalized nutrition
Irrespective of whether the commercial offering is made on
the Internet, personalized nutrition is not currently subject
to specific legal regulations. At the same time, although
business models for personalized nutrition offerings are
still, by and large, under development, current Internet
services (Ronteltap et al. 2012) already appear to reveal a
need to further guaranty legal certainty by ensuring privacy
and the highest standards of consumer protection and
safety. Three steps in delivering personalized nutrition
products particularly require attention from a legal per-
spective: (1) gathering personal information from the
consumer; (2) using the consumer’s data to (automatically)
generate personalized nutrition advice based on validated
algorithms; and (3) providing advice to the consumer. This
is obviously even more essential when the contact between
the consumer and the personalized nutrition provider is
conducted by means of the Internet (via the provider’s Web
site or via e-mail) throughout the process.
The extent of the legal implications of personalized
nutrition always depends on the stated purpose of the
personalized nutrition service offered, the legal status of
the provider, and the health status of the consumer. The
typical purpose of current offerings is to provide consumers
with personalized dietary or lifestyle advice (e.g., a pro-
posed recipe database, exercise regimes) based on self-
reported food-intake data (level 1), taking phenotype (level
2), or phenotype and genotype (level 3) into account.
Arguably, guiding consumers’ decision about diet or
exercise on the basis of measured polymorphism (levels 2
and 3) aims at participating in the prevention and treatment
352 Genes Nutr (2013) 8:349–355
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of certain diseases. Therefore, although no medical prac-
titioner or health-care provider need be directly involved in
the final personalized nutrition-delivering process, this type
of DTC business activity might be construed as pursuing a
medical objective, depending on the state of health of the
consumer. Rather than questionable disclaimers limiting
the liability of personalized nutrition advice providers
regarding the effect of such advice on the health of their
clients, the prerequisite for any personalized nutrition
offered to consumers by non-medical professionals should
arguably be as follows: compliance with clear criteria and
targeting various groups of consumers while taking into
account their state of health (e.g., no medical supervision
needed).
DTC testing devices1
Although not specific to personalized nutrition, two
directives of the European Union (EU) appear to be of
particular relevance: the Medical Diagnostic Devices
Directive (MDD) (MDD 1993) and the In Vitro Diagnostic
Devices Directive (IVDD) (IVDD 1998). Applying a broad
interpretation of their scope to include tests carried out in
the context of ‘‘lifestyle services,’’ such as personalized
nutrition, whether DTC tests are subject to pre-market
conformity assessment depends on the degree of risk
associated with their use (Human Genetics Commission
2003). Though DNA tests for medical purposes are clearly
covered by the current version of the IVDD, the situation
remains unclear with regard to DNA DTC tests for lifestyle
purposes.
This weakness in implementing the IVDD has become
evident since 2000. Its classification system has become
inadequate for the new in vitro diagnostic services.
Ongoing revision of the IVDD by the European Commis-
sion (public consultation by the European Commission2)
clearly intends to clarify the situation and to subject in vitro
diagnostic services to additional requirements related to
such issues as safety and quality. That being said, the issue
of the analytic or clinical validity and clinical utility of
DTC self-testing (including DNA testing) in the context of
lifestyle services will very likely be quite difficult to
address.
Consumers’ personal data
The Charter of Fundamental Rights of the European Union
recognizes in its Article 8 the right to the protection of
personal data (Charter of Fundamental Rights of the
European Union 2010). The Data Protection Directive and
the E-Privacy Directive specify a number of requirements,
exceptions, and safeguards relating to confidentiality and
security that interactive online services have to meet in
order to lawfully process sensitive data related to health in
the EU market (Data Protections Directive 1995; Proposal
for a General Data Protection Regulation 2012; Directive
on Privacy and Electronic Communications 2002). They
also prescribe sanctions and appropriate remedies in cases
of breach and establish enforcement mechanisms to make
those requirements effective.
Security and privacy-enhancing technologies appear to
offer an additional tool to ensure personal data protection
when personal data are disseminated through information
and communication technologies networks and the pro-
cessing of data crosses several jurisdictions (Communica-
tion on PETs 2007).
The processing of consumers’ personal data related to
health within the framework of commercial DTC rela-
tionships entails the necessity of a careful assessment of the
existing rules safeguarding fundamental rights and data
protection. This has to be evaluated in terms of the existing
solutions offered by information technology (today and in
the foreseeable future) to detect possible dangers leading to
the determination of whether specific legislation is needed.
The sensitivity of data related to health is recognized by
existing legislation. But—are the applicable requirements
appropriate in the context of DTC services that do not
involve health-care professionals subject to legal obliga-
tions of professional secrecy? Do the applicable require-
ments address all the risks posed by the particular
sensitivity of genetic information at each step of their
processing—collection, access, disclosure, storage, and
circulation? Do applicable requirements provide sufficient
guarantees for consumers against potential misuse or
abuse?
Personalized nutrition advice service
The typical current offerings—personalized dietary or
lifestyle advice provided to consumers by self-employed
economic operators for remuneration—should arguably be
regarded as a service covered by Directive 2006/123/EC on
services (Services Directive 2006). This is in contrast with
health-care services provided by health professionals to
1 DTC testing services involve obtaining (via post) consumers’
genetic information from blood samples (using, e.g., kits for thumb
pricking) and buccal cells (using, e.g., kits to take buccal swabs) for
checking DNA DTC testing.
2 Public Consultation by the European Commission, Health and
Consumers Directorate-General on the Revision of Directive 98/79/
EC of the European Parliament and of the Council of October 27,
1998, on in vitro diagnostic medical devices: (1) Questionnaire, June
2010, http://ec.europa.eu/enterprise/newsroom/cf/itemdetail.cfm?item_
id=4404. (2) Summary of responses, February 2011, http://ec
.europa.eu/health/medical-devices/files/recast_docs_2008/ivd_pc_out
come_en.pdf.
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patients since these services are excluded from the scope of
that directive. Moreover, like any service provided for
remuneration at a distance, by electronic means, and at the
individual request of the recipient, any such personalized
nutrition service is also regulated by Directive 2000/31/EC
(Directive on Electronic Commerce 2000). With regard to
commercial communications, the EU horizontal laws
governing the misleading promotion of services equally
apply to lifestyle services, such as those for personalized
nutrition (Misleading and Comparative Advertising
Directive 2006; Unfair Commercial Practices Directive
2005).
Taking into account their purpose (lifestyle services),
the nature of DTC tests required for obtaining genetic
information and the sensitive nature of that information,
personalized nutrition services are on the borderline
between nutrition and medicine. In our ongoing assessment
of whether the consumer, although not a patient, can be
assured of the highest quality of lifestyle offerings based on
genetic information and also be ensured privacy every-
where in the EU, the current developments in the ehealth
area at the EU level in the context of the eHealth action
plan (eHAP) 2012–2020 need to be closely monitored.3
Conclusions
Despite some concerns, consumers often have a positive
attitude to the option of receiving personalized nutrition
advice based on genetic testing. An important reason for
this seems to be the value of good health and, consequently,
the prospect of enhancing or maintaining one’s own health
can be perceived as empowering. Current Internet services
for delivering individual DTC advice based on lifestyle
information (such as food habits, phenotype information, or
individual DNA) suffer from a questionable level of truth-
fulness and consumer protection in addition to an imbalance
between far-reaching promises and contrasting disclaimers.
Psychological and behavioral studies indicate that con-
sumer acceptance of a new technology is primarily
explained by the end user’s rational and emotional inter-
pretation of the technology, including benefits, costs, risks,
and uncertainties, as well as moral beliefs. The means of
communication influence which of these characteristics
have the strongest influence on consumer acceptance. Fur-
thermore, consumer acceptance of personalized nutrition
relies on the creation of true value for the consumer and the
perception of personal freedom of choice.
From an ethical point of view, consumer protection is
crucial, and caution must be taken when putting nutrige-
nomic-based tests and advice services on the market.
Current Internet offerings appear to reveal a need to further
guaranty legal certainty by ensuring privacy and the
highest standards of consumer protection and safety. Three
steps in delivering personalized nutrition services particu-
larly require attention from a legal perspective: gathering
personal information from the consumer; using the con-
sumer’s data to generate personalized nutrition advice; and
providing the advice to the consumer.
Personalized nutrition services are on the borderline
between nutrition and medicine. Current regulation of this
area is incomplete and undergoing development. This sit-
uation entails the need to carefully assess and develop
existing rules safeguarding fundamental rights and data
protection; at the same time, it is necessary to take into
account the sensitivity of the data, the risks posed by each
step in their processing, and sufficient guarantees for con-
sumers against potential misuse or abuse. Rather than
questionable disclaimers limiting the liability of the pro-
viders, compliance with clear criteria targeting varying
groups of consumers, should be a prerequisite for any
personalized nutrition service.
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